Alder BioPharmaceuticals is now looking for a new chief executive, just as the company readies plans to file for FDA approval of its lead drug for migraine headaches.
Randy Schatzman (pictured above, right) is out as Alder’s (NASDAQ: ALDR) CEO,... Read more »
The fallout from Uber’s autonomous car fatality continues today, with a number of new developments. We’re recapping them very quickly here, and adding two reaction quotes we received from Carrie Morton, deputy director of the University of Michigan’s Mcity research facility... Read more »
Austin—SKU, a retail and consumer packaged goods-focused accelerator, launched its latest class of startups on Tuesday.
SKU was founded as Incubation Station in 2012 by Austin entrepreneur Shari Wynne, who told me in 2014 that the accelerator invests $8,000 into... Read more »
Mythic, which last year unveiled its novel computer chip designed for artificial intelligence, announced today that it has raised $40 million in a Series B fundraising round led by the venture capital arm of Japanese telecom and tech giant SoftBank... Read more »
Arena Pharamceuticals’ plan to reshape itself is advancing with new data for an ulcerative colitis drug that could pose a threat to biotech giant Celgene.
San Diego, CA-based Arena (NASDAQ: ARNA) said late Monday that its experimental compound etrasimod has... Read more »
San Antonio — CytoBioScience, a bioscience company that canceled plans to merge with a publicly traded business last year, may have new merger plans.
The San Antonio-based business raised a $1.53 million equity round of funding, according to a document filed... Read more »
The inevitable has happened. An autonomous Uber car hit a pedestrian in Tempe, AZ, and caused her death. The ride-hailing giant has suspended testing on driverless cars in Arizona, Pittsburgh, San Francisco, and Toronto, according to the New York Times.... Read more »
Advances in robotics and artificial intelligence technologies have stoked fears that machines are coming for humans’ jobs in a variety of industries. Some executives of robotics companies have tried to allay those concerns, arguing that in many cases, people’s roles will... Read more »
[Updated 3/19/18 5:06 p.m. See below.] Two months after Exact Sciences said it planned to introduce a new celebrity spokesperson to plug its stool-based screening test for colorectal cancer, the company has pulled back the curtain on who it... Read more »
Drug discovery startup twoXAR has raised $10 million in funding to support its efforts to build a pipeline of drug candidates found by its proprietary artificial intelligence technology.
SoftBank Ventures led the Series A round of financing, and was joined by... Read more »
Desktop Metal, the well-funded metal 3D-printing startup, is adding more money to its coffers from another high-profile investor.
Ford has led a new $65 million investment round in Burlington, MA-based Desktop Metal, the company announced Monday. Earlier backer Future Fund also... Read more »
[Updated, 3/19/18, 6:32 p.m. See below.] Unity Biotechnology is trying to treat age-related diseases where it says many of them start: the production of the cellular proteins that lead to the deterioration associated with age. The startup is gearing... Read more »
The Centers for Medicare & Medicaid Services, which administers the federal Medicare insurance program, will begin covering FDA-approved diagnostic tests that scan tumors for a range of genetic mutations. The news is a boost for companies like Foundation Medicine and Thermo... Read more »